Suppliers

The gut feeling is good between Probi and Institut Rosell as they extend probiotic link

Canadian Institut Rosell agrees probiotic deal with Probi

By Mike Stones

French Canadian company Institut Rosell has agreed a seven-year partnership with Swedish probiotic research and the development firm Probi covering dietary supplements based on its bacterial Lp299v strain.

EFSA affirms soy protein health claim rejection

EFSA explains soy protein claim rejection

By Shane Starling

The European Food Safety Authority health claims panel has defended its controversial rejection of a soy protein-cholesterol lowering submission in July this year by highlighting the fact the industry agreed to its tight definition of soy protein.

Food supplements remain popular in Poland

Food supplements drive sluggish Polish OTC growth

By Shane Starling

The Polish over-the-counter (OTC) market may be slowing due to lower sickness numbers, but food supplements continue to perform strongly, according to a new report from PMR Publications.

Martek becomes DSM's biggest acquisition since its 2002 purchase of Roche Vitamins

DSM buys Martek’s “algae platform” for $1bn+

By Shane Starling

Royal DSM will drive Martek’s predominantly US-based, omega-3 DHA infant nutrition business to new shores, and fast-track its food and beverage ambitions, after having its billion-dollar bid accepted by the Maryland company’s Board.

Professor Tine Rask Licht - Winner of the Danisco Award

The opportunities and obstacles for gut health science

By Nathan Gray

It’s been a bad year for good bacteria: A raft of negative health claims opinions from the European Food Safety Authority (EFSA) has left many in the industry predicting trouble ahead for probiotics and prebiotics in Europe. But Professor Tine Rask Licht,...

The food industry in 2010: A retrospective

The food industry in 2010: A retrospective

As 2010 draws to a close, our journalists look back at the issues that have topped agendas across the food, beverage and dietary supplements industries in the last 12 months. Commodity prices, Bisphenol A, obesity, health claims, safety regulations, and...

EFSA gives thumbs down to pre-submision meetings

EFSA Board: No resources for pre-submission claim meetings

By Shane Starling

The European Food Safety Authority (EFSA) confirmed at its Board Management meeting last week that the resources do not exist to accommodate meetings between its health claims panel and parties before claim submissions are formally made.

Could pre-health claim submission meetings actually save resources?

Probiotics industry unites over EFSA claims treatment

By Shane Starling

Four groups with an interest in pre- and probiotics will today send a letter to the European Commission and European Food Safety Authority spelling out their ongoing concerns with the European Union health claims system that, to date, has unanimously...

Provexis bemoans lack of functional food acquisitions

Provexis bemoans lack of functional food acquisitions

By Ben Bouckley

Windsor-based functional and medical food firm Provexis is actively seeking to acquire technology firms in the sector, with ceo Stephen Moon stating that its lack of purchases over the past six months has been “disappointing”.

Not even the economic slump could dent the digestive health category

“Feeling the benefit” guides 2011 trends

By Shane Starling

Products that deliver physiological benefits quickly such as those benefitting gut health or boosting energy – will be the most important trend for 2011, according to a new report.

A healthy immune system is proving difficult to define. Is this man's system healthy?

EFSA gut/immune health meeting

ERNA: EFSA must clarify ‘boundaries of immune normality’

By Shane Starling

The high rate of European Food Safety Authority (EFSA) immune health health claim rejections is likely to continue unless parameters of a well-functioning immune system can be defined, according to a Brussels-based industry group.

Nattopharma defends vitamin K patents

Nattopharma defends vitamin K patents

Norwegian vitamin K specialist Nattopharma has defended two pending patents in the cardiovascular area that affirm the ingredients can be used in the heart health sector.

Bischoff: Who will answer the

EFSA gut/immune health meeting

Health claims: Is the idea of disease risk factors, itself diseased?

By Shane Starling

Differentiating between disease risk factors and disease reduction in the way that the 2006 nutrition and health claim regulation does is too arbitrary and needs revision, according to a German nutrition professor. But if such a change is needed, who...

GSK flexes muscles with Maxinutrition buyout

GSK flexes muscles with Maxinutrition buyout

By Ben Bouckley

GlaxoSmithKline (GSK) has bought UK functional food firm Maxinutrition for around £162m, to secure a presence in the protein-based sports nutrition market.

Vitamin D can help the elderly reduce falls, says DSM, in a new submission

DSM submits vitamin D health claim for “falling”

By Shane Starling

DSM Nutritional Products has submitted an article 14 disease risk reduction health claim linking consumption of a proprietary blend of vitamin D2 and D3 and reduced risk of falling over among the elderly.

How to build an article 13.5 dossier

How to build an article 13.5 dossier

By Shane Starling

The rejection of so many health claim submissions by the European Food Safety Authority is creating a major headache for the EU functional foods and food supplements industries, with many looking at resubmissions under article 13.5 of the regulation.

How significant will the botanicals reprieve turn out to be?

NHCR botanicals removal provides a longevity loophole?

By Shane Starling

The European Commission decision to remove around 2000 submissions for botanical extracts from the 2006 nutrition and health claims process will allow substances to remain on-market, and may provide a loophole to help companies thinking about herbal medicinal...

Yakult wants a word with the NDA about its rejected probiotic immunity claim

Yakult: EFSA must recognise cold symptoms

By Shane Starling

Japanese probiotics giant Yakult says its recent EFSA probiotic health claim rejection discounted peer-review validated respiratory tract health measures, and called on the European Commission to facilitate a discussion on the matter.

NDA panelist: Restoring the immune sytem could yield claims

EFSA gut/immune health meeting

NDA panelist offers restored immune system claims hope

By Shane Starling

Restoring a suppressed immune system to full-function could win a health claim, EFSA health claim panelist, Henk van Loveren said at last week’s gut/immune health meeting in Amsterdam.

PepsiCo pays a high price for a gamble in Russian dairy

PepsiCo pays a high price for a gamble in Russian dairy

By Guy Montague-Jones

When PepsiCo put up $5.4bn last week to acquire Wimm-Bill-Dann, it was seduced by the promise of high revenue growth but like any high-yield investment the Russian deal does not come without risks.

CIAA is calling for greater dialogue with EFSA's health claims panel

EFSA gut/immune health meeting

CIAA calls for drug-like health claim pre-submission advice

By Shane Starling

The CIAA says EFSA’s immunity/gut health workshop has revealed the lack of clarity that remains in the European Union health claims process and called for pre-submission meetings between applicants and EFSA’s health claims panel.

EFSA is communicating more but industry may not like what it is hearing

EFSA gut/immune health meeting

EFSA gut/immune function meeting leaves industry wanting more

By Shane Starling

Key members of the European pre- and probiotic industries left Amsterdam frustrated that the majority of their questions about immune and gut health claims remained unanswered after a meeting with the European Food Safety Authority’s health claims panel...

City: Unilever strategy in emerging markets is 'hugely impressive'

City: Unilever strategy in emerging markets is 'hugely impressive'

By Elaine Watson

70% of Unilever’s sales could be generated in developing and emerging (D&E) markets by the end of the decade, according to City analysts covering a ‘hugely impressive’ investor seminar in Singapore run by the consumer products giant.

Defining the drug/food borderline is an

EFSA gut/immune health meeting

NDA details the food-drug divide and its “impossible task”

By Shane Starling in Amsterdam

“It’s a critical issue to figure out how to show the health benefits with foods without crossing the borderline into medicines,” European Food Safety Authority (EFSA) NDA health claims panel working group member, Maria Saarela, told NutraIngredients at...

Follow us

Products

View more

Webinars